AI heart platform

Echo IQ's EchoSolv running on a digital tablet

Sydney-based medtech Echo IQ brings AI heart screening platform to the US

By Adam Ang 12:02 am December 8, 2022

ASX-listed medical AI company Echo IQ has launched its cloud-based platform for screening structural heart disease in the United States. WHAT IT DOES The software platform called EchoSolv supports the identification of structural heart diseases, including guideline-defined aortic stenosis at present, automating this process using AI. It can also complete bulk assessments at a rate of up to 48,000...

Roundup: HeartLab scores $2M for US entry, Doctor Care Anywhere acquires GP2U Telehealth, and more briefs

By Adam Ang 02:20 am September 24, 2021

HeartLab raises $2M to bring AI heart software to US New Zealand startup HeartLab has bagged NZ$3.5 million ($2.4 million) from a funding round led by Silicon Valley venture capital firm Founders Fund. The company seeks to deploy its fresh funds to further penetrate the $1.5 billion AI tools market in the US with its AI-powered heart scanning and reporting platform called Pulse. It also plans to...